Estes Daniel J, Lopez Santiago R, Fuller A Oveta, Mayer Michael
Department of Biomedical Engineering, College of Engineering, University of Michigan, Ann Arbor, Michigan 48109, USA.
Biophys J. 2006 Jul 1;91(1):233-43. doi: 10.1529/biophysj.105.076398. Epub 2006 Apr 14.
We present a method that makes it possible to trigger, observe, and quantify membrane aggregation and fusion of giant liposomes in microfluidic chambers. Using electroformation from spin-coated films of lipids on transparent indium tin oxide electrodes, we formed two-dimensional networks of closely packed, surface-attached giant liposomes. We investigated the effects of fusogenic agents by simply flowing these molecules into the chambers and analyzing the resulting shape changes of more than 100 liposomes in parallel. We used this setup to quantify membrane fusion by several well-studied mechanisms, including fusion triggered by Ca2+, polyethylene glycol, and biospecific tethering. Directly observing many liposomes simultaneously proved particularly useful for studying fusion events in the presence of low concentrations of fusogenic agents, when fusion was rare and probabilistic. We applied this microfluidic fusion assay to investigate a novel 30-mer peptide derived from a recently identified human receptor protein, B5, that is important for membrane fusion during the entry of herpes simplex virus into host cells. This peptide triggered fusion of liposomes at an approximately 6 times higher probability than control peptides and caused irreversible interactions between adjacent membranes; it was, however, less fusogenic than Ca2+ at comparable concentrations. Closely packed, surface-attached giant liposomes in microfluidic chambers offer a method to observe membrane aggregation and fusion in parallel without requiring the use of micromanipulators. This technique makes it possible to characterize rapidly novel fusogenic agents under well-defined conditions.
我们提出了一种方法,该方法能够触发、观察并量化微流控腔室中巨型脂质体的膜聚集和融合。通过在透明氧化铟锡电极上旋涂脂质薄膜进行电铸,我们形成了紧密堆积、附着于表面的巨型脂质体二维网络。我们通过简单地将这些融合剂流入腔室并同时分析100多个脂质体由此产生的形状变化,来研究融合剂的作用。我们利用该装置通过几种经过充分研究的机制来量化膜融合,包括由Ca2+、聚乙二醇和生物特异性连接引发的融合。当融合罕见且具有概率性时,直接同时观察许多脂质体对于研究低浓度融合剂存在时的融合事件特别有用。我们应用这种微流控融合测定法来研究一种源自最近鉴定出的人类受体蛋白B5的新型30肽,该蛋白对于单纯疱疹病毒进入宿主细胞过程中的膜融合很重要。这种肽触发脂质体融合的概率比对照肽高约6倍,并导致相邻膜之间发生不可逆相互作用;然而,在可比浓度下,其融合性低于Ca2+。微流控腔室中紧密堆积、附着于表面的巨型脂质体提供了一种无需使用显微操作器即可并行观察膜聚集和融合的方法。该技术使得在明确界定的条件下快速表征新型融合剂成为可能。